In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nutraceutix Inc

Latest From Nutraceutix Inc

RedHill nears NDA for its version of GSK's Zofran

RedHill Biopharma has said it intends "to request a pre-NDA meeting with the FDA in the coming weeks to discuss a US NDA marketing approval application for RHB-102", its once-daily controlled release formulation of the antiemetic, ondansetron, for the prevention of nausea and vomiting in cancer patients.

Gastrointestinal Cancer

New Products In Brief

GOGO reformulates Purell sanitizer; Life Extension brews up glucose support supplement; AllergEase allergy lozenges out in time for spring; Cardia 7 claims “heartier omega” mantle; extended-release SCOLR supplements debut; Tom’s of Maine rolls out natural antiperspirant; more New Products In Brief.

Consumer Launches

New Products In Brief

GOGO reformulates Purell sanitizer; Life Extension brews up glucose support supplement; AllergEase allergy lozenges out in time for spring; Cardia 7 claims “heartier omega” mantle; extended-release SCOLR supplements debut; Tom’s of Maine rolls out natural antiperspirant; more New Products In Brief.

Consumer Launches

Start-Up Quarterly Statistics, Q2 2010

Highlights from the Q2 2010 review of start-up dealmaking: Biopharma, medical device and in vitro diagnostics startups raised a total of $606 million, an 83% hike from the previous quarter but a 30% drop from Q2 2009. Unlike Q1, which saw four spin-offs, Q2 had just one. Three acquisitions closed including J&J's purchase of respiratory-focused RespiVert. During the second quarter of 2010, several companies signed multiple agreements including Clovis Oncology.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
    • Drug Delivery
      • Controlled Release
  • Other Names / Subsidiaries
    • SCOLR, INC.
UsernamePublicRestriction

Register